Eligible commercially insured patients who are prescribed HEMLIBRA for an FDA-approved use can receive up to $15,000 per calendar year for drug costs. For more information, see full program Terms and Conditions.
The information contained in this section of the site is intended for US health care professionals and specialty pharmacy representatives only. Click “OK” if you are a health care professional or specialty pharmacy representative.
Eligible commercially insured patients who are prescribed HEMLIBRA for an FDA-approved use can receive up to $15,000 per calendar year for drug costs. For more information, see full program Terms and Conditions.
At any time, click this to change word size.